The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury
about
sameAs
Regulated expression of surface AMPA receptors reduces excitotoxicity in auditory neuronsEffects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injuryAxonal pathology in traumatic brain injury.A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.Neuroprotective strategies against calpain-mediated neurodegeneration.Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis.Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress.Therapy development for diffuse axonal injury.Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse.Mechanistic role of calpains in postischemic neurodegeneration.Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury.The role of calcium-activated protease calpain in experimental retinal pathology.Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.Control of photoreceptor autophagy after retinal detachment: the switch from survival to death.Calpain as a therapeutic target in traumatic brain injury.Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.An updated patent review of calpain inhibitors (2012 - 2014).Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.Identification and characterization of PEBP as a calpain substrate.Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.The "dark side" of endocannabinoids: a neurotoxic role for anandamide.Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury.Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.Genetic ablation of Nrf2 enhances susceptibility to acute lung injury after traumatic brain injury in mice.Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus.Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.The expression of PGC-1α in the mice brain after traumatic brain injury.M-Calpain Activation Facilitates Seizure Induced KCC2 Down Regulation
P2860
Q30480253-504E0730-99D6-4B32-A900-725ED7E514F2Q33934466-995AE2D9-4677-4005-8B9C-748557705F7CQ34160568-4B9D59ED-AC53-451A-AE74-7034C5FB938CQ34250254-73DF923C-42D4-46EE-ACC8-B4F3EF55B0FBQ34378362-8E415D40-2CD2-43E5-99C5-A53D8DBE641AQ34627266-03BB7867-C5F1-434C-99F6-6752E8FF6EAAQ35081723-E6258EB7-1A09-46EC-86EA-AEFFA430AD45Q35220928-42974ADE-3366-4F7C-B697-729F1720D221Q35589949-7006C678-5DE5-48A9-9636-3F5771DFB74AQ35921561-CB755567-9BF8-47F3-8D2F-ABC8C8ADDBF7Q36768885-12E1160A-AEA5-4638-A934-724934902ABCQ36912518-ED55F1D9-8E4C-4DAB-906E-DBF82E0DF3AFQ37029897-2C58B192-A2E8-4552-B8EA-DE34D530E56BQ37071475-61CE0A39-5CAC-4112-9FA9-F2A2AE1A93EAQ37113015-86C22BAD-89B6-4956-AC46-5FC06EF44D61Q37425364-90A67E2F-FC8E-465B-A7FB-FC08CE61B117Q37561222-A60FE4A1-C910-4242-9521-11E59E181C70Q37686765-8A157A02-39D7-43E4-A378-21FE237432E2Q37857282-DB36D460-5F18-40A7-BB9B-AF17AD05E2EBQ38109663-CAB53638-7417-4D19-8BC7-2027B5357079Q38268518-8DD73770-40F9-40D7-822E-F4DCD2E8B950Q38784171-84FE5E0B-CDFC-41C4-9D26-DE5F50DDD2A0Q40224274-26AE0DD7-0998-434B-871A-B8EF36EB07F8Q41997832-1B270267-F790-4463-B081-6FD77F01A79BQ42229910-4DB28A1F-E450-4CF3-A089-670C2A731C1FQ44885320-7428EA40-EAB4-4874-B694-C07C91B9C989Q45141097-4E13F84F-E95A-457A-90D4-0B98F54EF239Q45678701-FEE6B407-ACFC-4925-908D-728518110ABBQ46142501-BE1C5729-4705-415A-B25A-EDD021167189Q46778817-5CC50F3D-6A99-44F4-BBF2-63E403728ED3Q46844278-FF3A17EE-0ED6-48C1-A315-0CB7A6225F94Q47885151-1056B7DD-412B-4651-9CD4-2271AA0A9109Q48490952-44B7EA5D-2E8D-4574-86BF-C83B944C953EQ58729297-3465250D-830E-4A4D-931C-CEAFE23673BE
P2860
The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@ast
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@en
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@nl
type
label
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@ast
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@en
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@nl
prefLabel
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@ast
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@en
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@nl
P2093
P1476
The novel calpain inhibitor SJ ...... model of diffuse brain injury
@en
P2093
Bernath EE
Mitsuyoshi A
P304
P356
10.1089/089771501317095269
P407
P577
2001-11-01T00:00:00Z